Krempa David (CIK 1968254) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-14). Recent activity: Sell ETON (1,942 shares), Sell ETON (6,264 shares), Sell ETON (16,977 shares), Sell ETON (6,800 shares), Sell ETON (10,223 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-14 | Eton Pharmaceuticals, Inc. (ETON) | Chief Business Officer | Sell | 1,942 | $30,334 |
| 2025-12-12 | Eton Pharmaceuticals, Inc. (ETON) | Chief Business Officer | Sell | 6,264 | $106,488 |
| 2025-06-16 | Eton Pharmaceuticals, Inc. (ETON) | Chief Business Officer | Sell | 16,977 | $253,297 |
| 2025-06-16 | Eton Pharmaceuticals, Inc. (ETON) | Chief Business Officer | Sell | 6,800 | $100,436 |
| 2025-06-16 | Eton Pharmaceuticals, Inc. (ETON) | Chief Business Officer | Sell | 10,223 | $150,585 |
Source: SEC Form 4 filings · as of 2026-01-14